Top Markets
#1 Geodnet Geodnet +26.60%
#2 XPIN Network XPIN Network +25.65%
#3 Pons Pons +22.69%
#4 EXOD EXOD +22.08%
#5 Ore Ore +20.91%
#6 SSV Network SSV Network +19.17%
#7 The Black Bull The Black Bull +18.38%
#8 Derive Derive +18.03%
#9 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +17.50%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +17.34%
Coin of the day
Geodnet Geodnet
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Orexo AB Orexo AB

Orexo AB

ORX
Rang in Aktien #24895
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Aktienkurs
$1.57
Marktkapitalisierung
$55.01M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-28.94%
Land
SE
Handel Orexo AB (ORX)

Kategorie

Healthcare
EPS für Orexo AB (ORX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Orexo AB beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Orexo AB von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.41 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $0.52 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $0.02 -
HK